Jefferies analyst Keith Devas initiated coverage with a Buy rating on Kenvue, Inc. (KVUE – Research Report) today and set a price target ...

(Reuters) -Hedge fund Starboard Value has taken a stake in Kenvue, the consumer products company that makes Band-Aid, ...

Number of Hedge Fund Investors: 58 Personal care and housekeeping products are sold by Kenvue Inc. (NYSE:KVUE). It is the ...

Activist investor Starboard Value reportedly has taken a large stake in consumer health products maker Kenvue.

An exclusive Q&A with David Lickstein, Global Head of Packaging Innovation, Sustainability, and Experience, at Kenvue ...

Personal care and housekeeping products are sold by Kenvue Inc. (NYSE:KVUE). It is the world’s largest pure-play consumer health company by revenue, with $15 billion in annual revenue.

J.P. Morgan analyst Andrea Faria Teixeira has maintained their bullish stance on KVUE stock, giving a Buy rating on October 15. Andrea Faria ...

Activist hedge fund Starboard Value has reportedly taken a stake in Kenvue, sparking a pre-market stock surge.

Kenvue’s organic growth hinges on the firm’s ability to drive volume gains. And while the self-care category, which consists of well-known brands like Tylenol, Benadryl, and Zyrtec ...

Shares of Kenvue rose more than 5% in premarket trading Monday after The Wall Street Journal reported that activist investor Starboard Value has built a sizable stake in the consumer-products ...

"Care is very much an integral part of [who] we are," she said of Kenvue’s leadership philosophy, which she credits for the organization’s success attracting and retaining top talent ...

The Wall Street Journal reported late Sunday that Starboard Value sees Kenvue as having some of the top consumer brands in its sector, including Tylenol and Listerine, but wants t ...